EIGR insider transactions
Eiger BioPharmaceuticals Inc. (EIGR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
EIGR insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Eiger BioPharmaceuticals Inc., latest first. Follow anyone to get their next filing.
- Richard A Kayne10% owner, since October 2023+$72.8K
- Leen Kawas10% owner, since October 2023+$6,375
- Ingrid ChoongOfficer, since August 2023
- David ApelianOfficer, Director-$49K
- James VollinsOfficer, since April 2023
- William G KachioffOfficer, since April 2023
- Eldon C. Mayer IIIOfficer-$21.7K
- Erik AtkissonOfficer, since September 2021
- Thomas John DietzDirector+$92.8K-$26.3K
- Christine MurrayDirector-$6,104
- Jeffrey S GlennDirector+$128K
- Lisa Kelly-CroswellDirector, since July 2022
- Sriram RyaliOfficer-$12.7K
- Amit SachdevDirector
- Kim SablichDirector, since April 2021
- Evan LohDirector-$20.3K
- David A CoryOfficer, Director
- James P ShafferOfficer
- Stephana Eilene PattonOfficer
Recent Form 3, 4, and 5 filings for EIGR
- Kayne Richard A bought $72,815 worth of shares (278,239 units at $0.26) (SEC Form 4)4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- Kawas Leen bought $6,375 worth of shares (24,332 units at $0.26) (SEC Form 4)4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- New insider Kayne Richard A claimed ownership of 5,096,986 shares (SEC Form 3)3 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- New insider Kawas Leen claimed ownership of 4,367,100 shares (SEC Form 3)3 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Choong Ingrid4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 3: New insider Choong Ingrid claimed ownership of 33,500 shares3 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Apelian David4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Vollins James4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 3 filed by new insider Vollins James3 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 3 filed by new insider Kachioff William G3 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Mayer Eldon C. Iii4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Apelian David4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Mayer Eldon C. Iii4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Atkisson Erik4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Dietz Thomas John bought $71,580 worth of shares (50,000 units at $1.43)4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Murray Christine sold $6,104 worth of shares (5,000 units at $1.22), decreasing direct ownership by 31% to 11,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Dietz Thomas John sold $26,302 worth of shares (22,500 units at $1.17), decreasing direct ownership by 52% to 21,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Glenn Jeffrey S bought $127,950 worth of shares (100,000 units at $1.28), increasing direct ownership by 121% to 182,355 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Apelian David sold $49,030 worth of shares (5,000 units at $9.81) as part of a pre-agreed trading plan, decreasing direct ownership by 31% to 11,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Kelly-Croswell Lisa4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 3 filed by new insider Kelly-Croswell Lisa3 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Ryali Sriram sold $12,683 worth of shares (2,266 units at $5.60), decreasing direct ownership by 5% to 41,566 units (tax liability)4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Mayer Eldon C. Iii sold $9,275 worth of shares (1,657 units at $5.60), decreasing direct ownership by 3% to 60,468 units to cover withholding tax4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Sachdev Amit was granted 6,000 shares, increasing direct ownership by 60% to 16,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Ryali Sriram was granted 24,000 shares, increasing direct ownership by 121% to 43,832 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Sablich Kim was granted 6,000 shares4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Glenn Jeffrey S was granted 6,000 shares, increasing direct ownership by 8% to 82,355 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Mayer Eldon C. Iii was granted 16,000 shares, increasing direct ownership by 35% to 62,125 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Murray Christine was granted 6,000 shares, increasing direct ownership by 60% to 16,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Dietz Thomas John was granted 6,000 shares, increasing direct ownership by 16% to 43,500 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Apelian David was granted 6,000 shares, increasing direct ownership by 60% to 16,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Atkisson Erik was granted 6,000 shares4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Loh Evan was granted 6,000 shares, increasing direct ownership by 75% to 14,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Cory David A was granted 47,000 shares, increasing direct ownership by 38% to 169,183 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Mayer Eldon C. Iii sold $7,722 worth of shares (1,560 units at $4.95), decreasing direct ownership by 3% to 46,125 units to satisfy withholding obligation4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Atkisson Erik4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 3 filed by new insider Atkisson Erik3 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Mayer Eldon C. III4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Ryali Sriram4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4 filed by Sablich Kim4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 3 filed by Sablich Kim3 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: John Thomas Dietz bought $21,220 worth of Common Stock (2,500 units at $8.49), increasing direct ownership by 7% to 37,500 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: P James Shaffer was granted 11,875 units of Common Stock, increasing direct ownership by 68% to 29,296 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Amit Sachdev was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Sriram Ryali was granted 16,250 units of Common Stock, increasing direct ownership by 854% to 18,152 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Eilene Stephana Patton was granted 11,875 units of Common Stock, increasing direct ownership by 196% to 17,948 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Christine Murray was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Iii C. Eldon Mayer was granted 11,875 units of Common Stock, increasing direct ownership by 33% to 47,685 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: Evan Loh was granted 5,000 units of Common Stock and sold $20,280 worth of Common Stock (2,000 units at $10.14), increasing direct ownership by 60% to 8,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: S Jeffrey Glenn was granted 5,000 units of Common Stock, increasing direct ownership by 7% to 76,355 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: John Thomas Dietz was granted 5,000 units of Common Stock, increasing direct ownership by 17% to 35,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: A David Cory was granted 47,000 units of Common Stock, increasing direct ownership by 66% to 117,846 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)
- SEC Form 4: David Apelian was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units4 - Eiger BioPharmaceuticals, Inc. (0001305253) (Issuer)